These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11218337)

  • 1. BCG in immunization programmes.
    Wkly Epidemiol Rec; 2001 Feb; 76(5):33-9. PubMed ID: 11218337
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE CURRENT ASPECTS OF DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS OF COMPLICATIONS AFTER BCG VACCINATION].
    Tuberk Biolezni Legkih; 2010; (6):25-8. PubMed ID: 27534052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG vaccination of young adults at risk of tuberculosis: a meaningful precaution in low-prevalence settings?
    Larsson LO; Fjällbrant H; Widström O; Ridell M
    Int J Tuberc Lung Dis; 2011 May; 15(5):709. PubMed ID: 21756528
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccine protocols to optimise the protective efficacy of BCG.
    Griffin JF; Mackintosh CG; Slobbe L; Thomson AJ; Buchan GS
    Tuber Lung Dis; 1999; 79(3):135-43. PubMed ID: 10656112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination against tuberculosis].
    Buzy P
    Rev Infirm; 2006 Feb; (118):24-5. PubMed ID: 16562548
    [No Abstract]   [Full Text] [Related]  

  • 7. At a time of global BCG shortage, attempts at optimizing BCG dose and schedule is no longer the answer.
    Morales A; Siemens DR; Koti M
    Urol Oncol; 2021 Feb; 39(2):137-138. PubMed ID: 33218921
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic methods of postvaccinal complications after administration of BCG vaccine].
    Zwolska Z; Augustynowicz-Kopeć E; Zabost A; Ziołkowski J; Buchwald J; Płończak M; Walas W; Ziebiński M
    Przegl Epidemiol; 2004; 58 Suppl 1():123-8. PubMed ID: 15807170
    [No Abstract]   [Full Text] [Related]  

  • 9. The nonspecific effects of vaccines and the expanded program on immunization.
    Shann F
    J Infect Dis; 2011 Jul; 204(2):182-4. PubMed ID: 21673027
    [No Abstract]   [Full Text] [Related]  

  • 10. BCG vaccines: WHO position paper – February 2018.
    Wkly Epidemiol Rec; 2018 Feb; 93(8):73-96. PubMed ID: 29474026
    [No Abstract]   [Full Text] [Related]  

  • 11. [Safety of BCG vaccinations--adverse effects following immunization. Part II. Causes of complications. Clinical management].
    Szczuka I
    Przegl Epidemiol; 2002; 56(1):15-28. PubMed ID: 12150058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence behind the WHO guidelines: hospital care for children: what is the evidence that BCG vaccination should not be used in HIV-infected children?
    Bannister C; Bennett L; Carville A; Azzopardi P
    J Trop Pediatr; 2009 Apr; 55(2):78-82. PubMed ID: 19276146
    [No Abstract]   [Full Text] [Related]  

  • 13. [Safety BCG vaccinations--adverse effects following immunization. Part I. Types, occurrence and registrations].
    Szczuka I
    Przegl Epidemiol; 2002; 56(1):1-13. PubMed ID: 12150052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bladder tumour treatment: the real BCG definitive contra-indications].
    Neuzillet Y; Lebret T
    Prog Urol; 2010 Mar; 20 Suppl 1():S41-5. PubMed ID: 20493443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of BCG vaccination policy in Europe: 1994-96.
    Trnka L; Dankova D; Zitova J; Cimprichova L; Migliori GB; Clancy L; Zellweger JP
    Bull World Health Organ; 1998; 76(1):85-91. PubMed ID: 9615500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BCG vaccination. Immunological aspects].
    Salud Publica Mex; 1979; 21(3):321-8. PubMed ID: 550311
    [No Abstract]   [Full Text] [Related]  

  • 17. BCG installations for bladder cancer and latent tuberculosis infection.
    Hanson K
    Urol Nurs; 2002 Apr; 22(2):132-4. PubMed ID: 11993243
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of BCG Vaccination in Pediatric Liver Transplant Recipients.
    Kinoshita N; Shoji K; Funaki T; Fukuda A; Sakamoto S; Kasahara M; Miyairi I
    Transplantation; 2018 Apr; 102(4):e125. PubMed ID: 29346255
    [No Abstract]   [Full Text] [Related]  

  • 19. Selecting the right indicators to ensure optimised implementation of BCG vaccination policy.
    Thysen SM; Fisker AB;
    Vaccine; 2018 Jun; 36(24):3406-3407. PubMed ID: 29748032
    [No Abstract]   [Full Text] [Related]  

  • 20. Efforts of identifying the place of tb infection and bcg vaccination in the hygiene hypothesis of allergy.
    Omiadze K; Telia A; Khechinashvili G
    Georgian Med News; 2006 Jul; (136):61-5. PubMed ID: 16905848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.